Q1 2024 New Drug Report (January - March)

The following table represents a summary of medication changes in the market from Q1 2024 (January through March) that may potentially be seen in workers' compensation. These could be new drug approvals, new generics, withdrawals and discontinuations of certain products, as well as near-term pipeline products and patent expirations. There may be other labeled or off-label uses for these products that may or may not be supported by medical treatment guidelines.

In some cases, there may not be an exact date listed, so the assumption would be that the approval or patent expiration would be at some point during the listed month, quarter or year. For discontinued medications, dispensing may still continue until pharmacies have exhausted their existing supply. Anticipated approval dates and availability of generics are subject to final FDA approval. Please note that these lists are not all-inclusive.

If you have any questions, please contact your Clinical Account Executive or another member of your account team.